Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-5-18
pubmed:abstractText
Bevacizumab is an antiangiogenic compound developed to target tumour vessels. Its off-label use in ophthalmology requires in vitro testing on ocular cells.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-11344092, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-11678628, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-12360282, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-14685874, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-15625332, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-15664960, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-15886877, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-15911882, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-15936441, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16156141, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16156152, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16156153, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16170134, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16399431, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16458968, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16603955, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-16770255, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-17021318, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-17021319, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-3782302, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-7526212, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-7536000, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-7673356, http://linkedlifedata.com/resource/pubmed/commentcorrection/17179166-9801894
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0007-1161
pubmed:author
pubmed:issnType
Print
pubmed:volume
91
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
827-31
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Antipermeability and antiproliferative effects of standard and frozen bevacizumab on choroidal endothelial cells.
pubmed:affiliation
University Eye Hospital, Eberhard-Karls University Tuebingen, Schleichstrasse 12, D-72076 Tuebingen, Germany. swaantje.peters@gmx.de
pubmed:publicationType
Journal Article